Ticker

No recent analyst price targets found for IDRSF.

Latest News for IDRSF

Idorsia strengthens financial position with up to CHF 250 million loan from Pharmakon

Ad hoc announcement pursuant to Art. 53 LR Senior secured term loan of up to CHF 250 million with a 5‑year maturity at a fixed 7% interest rate First tranche will fully refinance the existing New Money Facility, maturing in May 2027 Eliminates near‑term debt maturities and strengthens balance sheet and liquidity profile Additional tranches available to fund targeted initiatives accelerating growth and long‑term…

GlobeNewsWire • Jun 9, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for IDRSF.

No Senate trades found for IDRSF.

No House trades found for IDRSF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top